Home Development Services: Low Solubility Compounds
 

Keywords :   


Development Services: Low Solubility Compounds

2013-03-06 11:27:05| drugdiscoveryonline Downloads

For tackling the bioavailability challenges of BCS (Biopharmaceutical Classification System) class II and IV compounds, proven formulation development, analytical and manufacturing capabilities are available at Patheon’s facilities. A variety of approaches are often needed to improve the bioavailability of low solubility BCS class II and IV compounds. Patheon’s Pharmaceutical Development Services combines biopharmaceutics knowledge, preformulation data, and manufacturing technologies with statistical Design of Experiments to overcome bioavailability challenges.

Tags: services low development compounds

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
27.11 (uF6-060903
27.11 CD
27.11 155cm SALOMON 2461
27.11CISA &1227
27.11 110
27.11Lisa Larson 15271
27.1110REBORN
27.11CD glitsmotel urge blue
More »